Motor Neuron Disease (ALS)
Motor neuron disease is a progressive neurodegenerative condition characterised by the selective degeneration of motor neurons responsible for voluntary movement. The most common form is Amyotrophic lateral sclerosis, which affects both upper and lower motor neurons. As motor neurons degenerate, the ability to initiate and control movement is progressively lost.
Motor neuron disease presents complex clinical and ethical challenges. Cognition is often preserved while physical function declines, requiring careful assessment, anticipatory care planning, and sensitive communication throughout the disease trajectory.
What You Need to Know
Motor neuron disease, also known as amyotrophic lateral sclerosis, is a progressive neurodegenerative condition caused by loss of both upper motor neurons in the motor cortex and lower motor neurons in the brainstem and spinal cord. Upper motor neurons normally regulate and coordinate voluntary movement by influencing lower motor neuron activity, while lower motor neurons provide the final pathway between the nervous system and skeletal muscle. Degeneration at both levels disrupts motor control in a cumulative way.
As motor neurons are lost, muscles are progressively deprived of neural input. This leads to weakness, muscle wasting, and loss of voluntary movement that worsen over time. Because the disease targets motor pathways selectively, sensory neurons are largely unaffected, so sensation remains intact. Autonomic pathways are also relatively spared, and cognitive function is often preserved, particularly in early stages, meaning individuals remain aware of their physical decline.
At an overview level, motor neuron disease involves several key processes:
Degeneration of upper motor neurons causing loss of motor regulation and increased tone
Degeneration of lower motor neurons leading to muscle denervation and atrophy
Progressive motor impairment without primary sensory loss
The combination of upper and lower motor neuron involvement produces a characteristic pattern of weakness, muscle wasting, and functional decline. This selective vulnerability of motor pathways explains why motor neuron disease leads to profound physical disability while sensation and awareness are often preserved throughout much of the disease course.
Beyond the Basics
Upper and lower motor neuron degeneration
Motor neuron disease involves simultaneous degeneration of both upper and lower motor neurons, which produces a distinctive combination of clinical features. Upper motor neuron degeneration disrupts inhibitory signalling from the motor cortex, leading to increased muscle tone, spasticity, exaggerated reflexes, and loss of fine motor control. These changes occur because descending pathways that normally dampen reflex activity are no longer able to regulate lower motor neuron output.
Lower motor neuron degeneration affects the final common pathway between the nervous system and skeletal muscle. When lower motor neurons degenerate, muscles lose direct neural input, resulting in flaccid weakness, visible muscle wasting, and fasciculations, which are spontaneous twitching of denervated muscle fibres. The coexistence of spasticity and flaccid weakness indicates failure of motor control at multiple levels rather than pathology confined to a single anatomical site.
Cellular mechanisms of neurodegeneration
At a cellular level, motor neuron disease involves several overlapping mechanisms that place extreme stress on vulnerable neurons. Abnormal protein aggregation interferes with normal cellular function, while glutamate-mediated excitotoxicity, meaning injury caused by excessive excitatory neurotransmitter activity, promotes sustained depolarisation and calcium influx. Elevated intracellular calcium damages mitochondria, impairing energy production and accelerating cell injury.
Motor neurons are particularly susceptible because of their long axons and high metabolic demands. Efficient axonal transport is required to move proteins, organelles, and nutrients between the cell body and distal synapses. When this transport system becomes impaired, essential cellular components fail to reach their targets, leading to progressive dysfunction and eventual neuronal death. Unlike peripheral nerves, the central nervous system has very limited capacity to replace lost motor neurons, making this injury irreversible.
Progressive loss of motor reserve
In the early stages of motor neuron disease, surviving motor neurons may partially compensate for neuronal loss by increasing their firing rate or innervating additional muscle fibres. This temporary adaptation helps preserve muscle strength and function despite ongoing degeneration. However, this compensatory capacity is finite.
As degeneration continues, motor reserve becomes exhausted. Fewer functional motor units remain, and the ability to maintain muscle strength declines rapidly. Once this threshold is crossed, functional deterioration accelerates, with previously subtle deficits becoming overt weakness. This pattern accounts for the often uneven progression of motor neuron disease, where periods of relative stability may be followed by rapid loss of function over a short time.
Clinical Connections
Progressive weakness in motor neuron disease affects limb, bulbar, and respiratory muscle groups as motor neuron loss advances. Limb involvement leads to declining mobility, difficulty with transfers, and loss of independence as both upper and lower motor neuron dysfunction impair strength and coordination. Bulbar involvement causes dysarthria and dysphagia due to weakness of the muscles responsible for speech and swallowing, increasing the risk of aspiration, malnutrition, and social withdrawal.
Several patterns signal advancing disease and rising clinical risk:
Worsening swallowing difficulty or voice change indicating bulbar muscle involvement
Declining cough strength or breathlessness suggesting respiratory muscle weakness
Increasing fatigue and reduced functional reserve as motor units are progressively lost
Respiratory muscle weakness often develops gradually and may be underestimated until ventilatory capacity is significantly reduced. Weakness of the diaphragm and intercostal muscles impairs effective ventilation and secretion clearance, making respiratory failure a major contributor to morbidity and mortality. Because sensory pathways and cognition are usually preserved, individuals remain fully aware of physical decline, which can be psychologically distressing.
Care priorities centre on safety, comfort, and quality of life as motor function deteriorates. Ongoing assessment of respiratory function, swallowing safety, and communication needs supports timely intervention and anticipatory planning. Understanding that degeneration selectively affects motor pathways explains why strength and speech decline relentlessly despite intact sensation and awareness, reinforcing the focus on symptom management, supportive care, and early discussions around goals and preferences as the disease progresses.
Concept Check
Why does motor neuron disease affect movement but not sensation?
How do upper and lower motor neuron degeneration produce different clinical signs?
Why are motor neurons particularly vulnerable to neurodegeneration?
How does loss of motor reserve contribute to accelerating functional decline?
Why is respiratory monitoring critical in motor neuron disease?